VKaramyan TTUHSC 3.jpeg (IMAGE)

Texas Tech University Health Sciences Center

VKaramyan TTUHSC 3.jpeg

Caption

In his most recent study, TTUHSC’s Vardan Karamyan, Ph.D., led a collaborative investigation to evaluate the potential of neurolysin as a therapeutic target for stroke.

Credit

TTUHSC

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.